Encompass Health Co. (NYSE:EHC) Shares Purchased by First Trust Advisors LP

First Trust Advisors LP increased its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 20.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 284,774 shares of the company's stock after acquiring an additional 47,668 shares during the quarter. First Trust Advisors LP owned about 0.28% of Encompass Health worth $26,299,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. CANADA LIFE ASSURANCE Co grew its stake in shares of Encompass Health by 3.1% during the fourth quarter. CANADA LIFE ASSURANCE Co now owns 82,649 shares of the company's stock worth $7,627,000 after acquiring an additional 2,515 shares during the last quarter. NewEdge Advisors LLC increased its stake in Encompass Health by 5.3% during the 4th quarter. NewEdge Advisors LLC now owns 8,209 shares of the company's stock valued at $758,000 after purchasing an additional 412 shares in the last quarter. Jump Financial LLC purchased a new position in shares of Encompass Health in the fourth quarter worth $2,501,000. Icon Advisers Inc. Co. lifted its stake in shares of Encompass Health by 23.2% during the fourth quarter. Icon Advisers Inc. Co. now owns 35,840 shares of the company's stock worth $3,310,000 after buying an additional 6,740 shares during the period. Finally, Mariner LLC grew its holdings in shares of Encompass Health by 24.6% during the fourth quarter. Mariner LLC now owns 4,251 shares of the company's stock valued at $393,000 after buying an additional 838 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Insider Activity

In other Encompass Health news, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the transaction, the executive vice president now directly owns 79,710 shares of the company's stock, valued at $9,149,910.90. The trade was a 11.15 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.10% of the company's stock.

Encompass Health Price Performance

EHC traded down $0.75 during midday trading on Thursday, hitting $116.24. 227,388 shares of the company traded hands, compared to its average volume of 680,367. The company has a market capitalization of $11.71 billion, a price-to-earnings ratio of 26.10, a PEG ratio of 2.31 and a beta of 0.87. The business has a 50 day simple moving average of $101.07 and a two-hundred day simple moving average of $98.96. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 52-week low of $82.38 and a 52-week high of $117.52.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping the consensus estimate of $1.19 by $0.18. The company had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Encompass Health's quarterly revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.12 EPS. On average, equities analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.59%. Encompass Health's payout ratio is 14.05%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on EHC. StockNews.com raised Encompass Health from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. KeyCorp upped their target price on Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a research report on Friday, April 25th. Barclays increased their price target on shares of Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a report on Friday, April 25th. Truist Financial restated a "buy" rating and set a $135.00 price objective (up from $116.00) on shares of Encompass Health in a research note on Monday. Finally, UBS Group increased their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research note on Monday. Nine analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $120.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.